International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(3), С. 2085 - 2085
Опубликована: Янв. 20, 2023
Mesenchymal
stem
cells
(MSCs),
as
a
kind
of
pluripotent
cells,
have
attracted
much
attention
in
orthopedic
diseases,
geriatric
metabolic
and
sports
functions
due
to
their
osteogenic
potential,
chondrogenic
differentiation
ability,
adipocyte
differentiation.
Anti-inflammation,
anti-fibrosis,
angiogenesis
promotion,
neurogenesis,
immune
regulation,
secreted
growth
factors,
proteases,
hormones,
cytokines,
chemokines
MSCs
been
widely
studied
liver
kidney
cardiovascular
cerebrovascular
diseases.
In
recent
years,
many
studies
shown
that
the
extracellular
vesicles
similar
transplantation
all
above
aspects.
Here
we
review
research
progress
exocrine
years.
Advanced Science,
Год журнала:
2024,
Номер
unknown
Опубликована: Июль 8, 2024
Intervertebral
disc
degeneration
(IVDD)
is
a
chronic
degenerative
disease
involving
the
aging
and
loss
of
proliferative
capacity
nucleus
pulposus
cells
(NPCs),
processes
heavily
dependent
on
mitochondrial
dynamics
autophagic
flux.
This
study
finds
that
absence
BCL2/adenovirus
E1B
19
kDa
interacting
protein
3
(BNIP3)
associated
with
senescence-related
NPC
degeneration,
disrupting
quality
control.
Bone
marrow
mesenchymal
stem
(BMSCs)
have
multidirectional
differentiation
potential
produce
extracellular
vesicles
containing
cellular
activators.
Therefore,
in
this
study,
BMSCs
are
induced
under
hypoxic
stimulation
to
deliver
BNIP3-rich
NPCs,
thereby
alleviating
aging-associated
flux,
promoting
damaged
clearance,
restoring
Mechanistically,
BNIP3
shown
interact
membrane-bound
annexin
A2
(ANXA2),
enabling
liberation
transcription
factor
EB
(TFEB)
from
ANXA2-TFEB
complex,
TFEB
nuclear
translocation,
regulating
autophagy
lysosomal
gene
activation.
Furthermore,
rat
model
IVDD
established
verified
vivo
efficacy
exosomes
repairing
injuries,
delaying
aging,
matrix
(ECM)
synthesis.
In
summary,
hypoxia-induced
BMSC
alleviate
by
activating
BNIP3/ANXA2/TFEB
axis,
providing
new
target
for
treatment.
Regenerative Therapy,
Год журнала:
2024,
Номер
25, С. 355 - 366
Опубликована: Фев. 14, 2024
As
a
prominent
research
area
in
tissue
repair
and
regeneration,
mesenchymal
stem
cells
(MSCs)
have
garnered
substantial
attention
for
their
potential
the
treatment
of
various
diseases.
It
is
now
widely
recognized
that
therapeutic
effects
MSCs
primarily
occur
through
paracrine
mechanisms.
Among
these
mechanisms,
exosomes
play
crucial
role
by
exerting
series
regulatory
on
surrounding
tissues.
While
shown
promise
treating
diseases,
they
do
some
limitations,
such
as
limited
secretion,
poor
targeting,
single
functionality.
However,
MSC
preconditioning
can
enhance
production
exosomes,
lead
to
more
stable
functionality
improve
effects.
Moreover,
could
also
serve
carriers
specific
drugs
or
genes,
enabling
precise
treatments
This
review
summarizes
most
recent
literatures
how
influences
regenerative
provides
new
insights
into
application
derived
from
MSCs.
Advanced Drug Delivery Reviews,
Год журнала:
2024,
Номер
207, С. 115203 - 115203
Опубликована: Фев. 9, 2024
MSCs
are
used
for
treatment
of
inflammatory
conditions
or
regenerative
purposes.
complete
cells
and
allogenic
transplantation
is
in
principle
possible,
but
mostly
autologous
use
preferred.
In
recent
years,
it
was
discovered
that
secrete
extracellular
vesicles.
These
active
budded
off
vesicles
carry
a
cargo.
The
cargo
can
be
miRNA,
protein,
lipids
etc.
transported
through
the
body
fuse
with
target
cells.
Thereby,
they
influence
phenotype
modulate
disease.
have,
like
MSCs,
immunomodulatory
capacities.
This
review
will
focus
on
those
features
discuss
their
dual
role.
Besides
immunomodulation,
regeneration
concentrate
bone,
cartilage,
tendon,
vessels
nerves.
Current
clinical
trials
immunomodulation
started
last
five
years
highlighted
as
well.
summary,
have
great
potential
disease
modulating
entity
treatment.
Their
characteristics
need
to
taken
into
account
often
both
important
having
best
effect.
Stem Cell Research & Therapy,
Год журнала:
2024,
Номер
15(1)
Опубликована: Фев. 5, 2024
Abstract
Preeclampsia
(PE)
is
a
common
morbid
complication
during
pregnancy,
affecting
2%-8%
of
pregnancies
globally
and
posing
serous
risks
to
the
health
both
mother
fetus.
Currently,
only
effective
treatment
for
PE
timely
termination
which
comes
with
increased
perinatal
risks.
However,
there
no
way
delay
pathological
progress
improve
maternal
fetal
outcomes.
In
light
this,
it
great
significance
seek
therapeutic
strategies
PE.
Exosomes
are
nanoparticles
carrying
bioactive
substances
such
as
proteins,
lipids,
nucleic
acids,
have
emerged
novel
vehicle
intercellular
communication.
Mesenchymal
stem
cell-derived
exosomes
(MSC-Exos)
participate
in
various
important
physiological
processes,
including
immune
regulation,
cell
proliferation
migration,
angiogenesis,
shown
promising
potential
tissue
repair
disease
treatment.
Recently,
MSC-Exos
therapy
has
gained
popularity
ischaemic
diseases,
dysfunction,
inflammatory
other
fields
due
their
minimal
immunogenicity,
characteristics
similar
donor
cells,
ease
storage,
low
risk
tumor
formation.
This
review
elaborates
on
mechanism
treating
preeclampsia,
considering
main
pathogenic
factors
condition,
placental
vascular
dysplasia,
immunological
disorders,
oxidative
stress,
based
biological
function
MSC-Exos.
Additionally,
we
discuss
depth
advantages
challenges
acellular
agent
preeclampsia
iScience,
Год журнала:
2024,
Номер
27(2), С. 108955 - 108955
Опубликована: Янв. 19, 2024
Hepatocellular
carcinoma
(HCC)
is
a
highly
malignant
tumor
with
rich
blood
supply.
HCC-derived
exosomes
containing
hereditary
substances
including
microRNAs
(miRNAs)
were
involved
in
regulating
angiogenesis
and
metastasis.
Subsequently,
series
experiments
performed
to
evaluate
the
effect
of
exosomal
miR-3174
on
HCC
was
ingested
by
human
umbilical
vein
endothelial
cells
(HUVECs)
which
HIPK3
targeted
silenced,
causing
subsequent
inhibition
Fas
p53
signaling
pathways.
Furthermore,
induced
permeability
HUVECs
enhance
progression
Under
hypoxia,
upregulated
HIF-1α
further
promoted
transcription
miR-3174.
Moreover,
HNRNPA1
augmented
package
into
exosomes.
Clinical
data
analysis
confirmed
that
patients
high-level
correlated
worse
prognosis.
Thus,
hypoxia
promotes
metastasis
inhibiting
HIPK3/p53
HIPK3/Fas
Our
findings
might
provide
potential
targets
for
anti-tumor
therapy.
Military Medical Research,
Год журнала:
2024,
Номер
11(1)
Опубликована: Июль 22, 2024
Abstract
Background
Parkinson’s
disease
(PD)
is
a
neurodegenerative
disorder
characterized
by
the
degeneration
of
dopaminergic
neurons
in
substantia
nigra
(SN).
Activation
neuroinflammatory
response
has
pivotal
role
PD.
Mesenchymal
stem
cells
(MSCs)
have
emerged
as
promising
therapeutic
approach
for
various
nerve
injuries,
but
there
are
limited
reports
on
their
use
PD
and
underlying
mechanisms
remain
unclear.
Methods
We
investigated
effects
clinical-grade
hypoxia-preconditioned
olfactory
mucosa
(hOM)-MSCs
neural
functional
recovery
both
models
patients,
well
preventive
mouse
To
assess
improvement
induced
hOM-MSCs
exposure,
we
employed
single-cell
RNA
sequencing
(scRNA-seq),
assay
transposase
accessible
chromatin
with
high-throughput
(ATAC-seq)
combined
full-length
transcriptome
isoform-sequencing
(ISO-seq),
assay.
Furthermore,
present
findings
from
an
initial
cohort
patients
enrolled
phase
I
first-in-human
clinical
trial
evaluating
safety
efficacy
intraspinal
transplantation
hOM-MSC
into
severe
patients.
Results
A
identified
that
transforming
growth
factor-β1
(TGF-β1),
secreted
hOM-MSCs,
played
critical
modulating
mitochondrial
function
neurons.
This
effect
was
achieved
through
improving
microglia
immune
regulation
autophagy
homeostasis
SN,
which
closely
associated
responses.
Mechanistically,
exposure
to
led
neuroinflammation
partially
mediated
TGF-β1
via
activation
anaplastic
lymphoma
kinase/phosphatidylinositol-3-kinase/protein
kinase
B
(ALK/PI3K/Akt)
signaling
pathway
located
SN
improved
neurologic
regulated
without
any
adverse
reactions
observed
Conclusions
These
provide
compelling
evidence
involvement
mediating
beneficial
Treatment
prevention
could
be
effective
neuroprotective
strategy
Additionally,
may
used
alone
or
therapy
treating
Stem Cells International,
Год журнала:
2022,
Номер
2022, С. 1 - 24
Опубликована: Март 26, 2022
Hypoxia-mimetic
agents
are
new
potential
tools
in
MSC
priming
instead
of
hypoxia
incubators
or
chambers.
Several
pharmaceutical/chemical
hypoxia-mimetic
can
be
used
to
induce
the
tissues:
deferoxamine
(DFO),
dimethyloxaloylglycine
(DMOG),
2,4-dinitrophenol
(DNP),
cobalt
chloride
(CoCl2),
and
isoflurane
(ISO).
increase
cell
proliferation,
preserve
enhance
differentiation
potential,
migration
neovascularization
a
concentration-
stem
source-dependent
manner.
Moreover,
may
HIF-1α,
changing
metabolism
enhancing
glycolysis
like
hypoxia.
So,
there
is
clear
evidence
that
treatment
with
beneficial
regenerative
medicine,
preserving
capacities.
These
not
studied
so
wildly
as
but,
considering
low
cost
ease
use,
believed
find
application
pretreatment
many
diseases
such
ischemic
heart
disease
myocardial
fibrosis
promote
cardiac
cartilage
regeneration.
The
knowledge
critical
evaluating
safety
procedures
use
clinics.
In
this
review,
similarities
differences
between
terms
their
therapeutic
efficiency
considered
detail.
advantages,
challenges,
future
perspectives
mimetic
also
discussed.
Molecular Therapy,
Год журнала:
2023,
Номер
31(5), С. 1365 - 1382
Опубликована: Фев. 2, 2023
Mesenchymal
stem
cells
regulate
remote
intercellular
signaling
communication
via
their
secreted
extracellular
vesicles.
Here,
we
report
that
menstrual
blood-derived
alleviate
acute
lung
inflammation
and
injury
vesicle-transmitted
miR-671-5p.
Disruption
of
this
abundantly
expressed
miR-671-5p
dramatically
reduced
the
ameliorative
effect
vesicles
released
by
on
lipopolysaccharide
(LPS)-induced
pulmonary
inflammatory
injury.
Mechanistically,
directly
targets
kinase
AAK1
for
post-transcriptional
degradation.
is
found
to
positively
activation
nuclear
factor
κB
(NF-κB)
controlling
stability
inhibitory
protein
IκBα.
This
study
identifies
a
potential
molecular
basis
how
derived
from
mesenchymal
improve
highlights
functional
importance
miR-671-5p/AAK1
axis
in
progression
diseases.
More
importantly,
provides
promising
cell-based
approach
treatment
disorders
through
an
vesicle-dependent
pathway.